Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
Beneficiaries in five states described what happened when they received demands to return overpayments that reached up to tens of thousands of dollars or more.
The annual U.S. Census Bureau report this week revealed a drop in the uninsured rate last year as more working-age people obtained employer coverage. However, this year’s end of pandemic-era protections — which allowed many people to stay on Medicaid — is likely to have changed that picture quite a bit since. Meanwhile, reports show […]
High-risk patients from states that heavily restrict abortion are coming to hospitals in states such as Illinois that protect abortion rights. The journey can mean more medical risks and higher bills.
Doctors say billing for email consultations reduces message volume and gives them more free time. The increasingly prevalent practice has also raised fears about negative impacts to patient care.
As covid-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters — and not only for those at highest risk of serious disease. Here are seven things you need to know.
This installment of InvestigateTV and KFF Health News’ “Costly Care” series delves into the lack of cost protections for patients who find themselves on the hook for an emergency ground ambulance ride.
Chances are, if you aren’t older, chronically ill, or obese, you don’t need a forthcoming covid vaccine to stay out of the hospital. But it probably wouldn’t hurt.
As cities like Denver struggle to make homes more affordable, medical debt keeps housing out of reach for millions of Americans.
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
